http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0203954-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98647babc96c2db824087cb0d5e0dbed http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11ebf43887482ff61c505773f3ad744a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1957f367d8301465343a413fd9e402aa |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
| filingDate | 2001-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf456619d95a64666cb33bca2ac5efc1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c6671c66f509d24430d618e8e8ae7ae |
| publicationDate | 2002-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-0203954-A2 |
| titleOfInvention | Non swellable suppository comprising at least one biocompatible, non-biodegradable polymer and a controlled release formulation |
| abstract | There is provided a suppository comprising at least one biocompatible polymer, wherein the biocompatible polymer is essentially non-biodegradable, and wherein the suppository essentially does not swell when contacted with an aqueous fluid. The suppository may further comprise a plurality of open cells at least partly separated from one another by an interpenetrating matrix comprising at least one biocompatible polymer in branched or crosslinked form. The plurality of interlinked, open cells are capable of containing an aqueous fluid, and the permeability of the suppository ensures that entry of body fluids into the open cells under practical circumstances occurs essentially without dehydration of mucousal membrane tissue contacting the suppository. The suppository futhermore preferably comprises a controlled release formulation. |
| priorityDate | 2000-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 3028.